02:07 PM EDT, 10/10/2025 (MT Newswires) -- Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling about 0.9%.

The iShares Biotechnology ETF (IBB) was shedding 1.3%.

In corporate news, Bristol-Myers Squibb ( BMY ) agreed to buy privately-held Orbital Therapeutics in an all-cash deal worth about $1.5 billion to boost its cell therapy portfolio. Bristol shares were down 1.5%.

AstraZeneca ( AZN ) has agreed on a deal with President Donald Trump to lower drug prices in the US, and an agreement could be announced later in the day, MSNBC reported Friday, citing a White House official. AstraZeneca ( AZN ) shares were down 0.4%.

Johnson & Johnson ( JNJ ) is in talks to buy Protagonist Therapeutics ( PTGX ) , The Wall Street Journal reported Friday. Johnson & Johnson ( JNJ ) eased 0.2%, and Protagonist surged 32%.

Usana Health Sciences ( USNA ) shares tumbled 21% after it reported late Thursday preliminary Q3 results, saying it swung to an adjusted loss from a profit a year earlier.